University of Pennsylvania (Site 1047) — Philadelphia, Pennsylvania

University of Pennsylvania (Site 1047) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennsylvania (Site 1047) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania (Site 1047)?

University of Pennsylvania (Site 1047) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania (Site 1047) conducted?

University of Pennsylvania (Site 1047) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is University of Pennsylvania (Site 1047) accredited by Crixeo Health?

University of Pennsylvania (Site 1047) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania (Site 1047)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.